Open Access

Implementing in-hospital initiation of an SGLT2 inhibitor in my practice.

Topic: Chronic Heart Failure, Other
Sponsored by Boehringer Ingelheim & Eli Lilly

Congress Session

About the speaker

Doctor Maria Rosa Costanzo

Advocate Heart Institute, Naperville (United States of America)
23 presentations
1 follower

4 more presentations in this session

Introduction and recap.

Speaker: Professor J. Butler (Jackson, US)


What is the evidence for SGLT2 inhibitors in HF?

Speaker: Professor P. Ponikowski (Wroclaw, PL)


Panel discussion.

Speaker: Professor S. Anker (Berlin, DE)


SGLT2 inhibitors in practice: what are the next steps?

Speaker: Professor S. Anker (Berlin, DE)


Access the full session

SGLT2 inhibitors in practice (part 4): initiating heart failure treatment in hospital

Speakers: Doctor M. Costanzo, Professor J. Butler, Professor P. Ponikowski, Professor S. Anker, Professor S. Anker

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk